Zdrowie i gospodarka · 05/10/2021

FDA Publishes Draft Guidance on Carcinogenicity Testing for Pharmaceuticals

The FDA has released a draft guidance from the International Council for Harmonisation, outlining an updated approach to assessing human carcinogenic risk for small molecule pharmaceuticals, including a new plasma exposure ratio-based method for setting high doses in animal studies.